Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
ANNÉE
2021
AUTEURS
Dahan L, Williet N, Le Malicot K, Phelip JM, Desrame J, Bouche O, Petorin C, Malka D, Rebischung C, Aparicio T, Lecaille C, Rinaldi Y, Turpin A, Bignon AL, Bachet JB, Seitz JF, Lepage C, Francois E, PRODIGE 35 Investigators/Collaborators
CONGRÈS/REVUE
J Clin Oncol
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES